Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))

Tai W.-T.ANN-LII CHENGShiau C.-W.Huang H.-P.Huang J.-W.PEI-JER CHENChen K.-F.2021-07-032021-07-0320170168-8278https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019248410&doi=10.1016%2fj.jhep.2017.02.021&partnerID=40&md5=e1ec01afb3e48f6103e738e71ec0125fhttps://scholars.lib.ntu.edu.tw/handle/123456789/568364Corrigendum to “Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma” (Journal of Hepatology (2017) 66(3) (666–668) (S0168827816307127) (10.1016/j.jhep.2016.12.007))corrigendum10.1016/j.jhep.2017.02.021283023832-s2.0-85019248410